These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29496230)

  • 1. Role of voltage-gated sodium channel blockers in the treatment of chronic pain: Potential uses in clinical practice based on available evidence.
    Alcántara Montero A; Sánchez Carnerero CI
    Rev Esp Anestesiol Reanim (Engl Ed); 2018 May; 65(5):275-283. PubMed ID: 29496230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Old Friends With New Faces: Are Sodium Channel Blockers the Future of Adjunct Pain Medication Management?
    Thomas AM; Atkinson TJ
    J Pain; 2018 Jan; 19(1):1-9. PubMed ID: 28842369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EPICON consensus: recommendations for proper management of switching to eslicarbazepine acetate in epilepsy.
    Villanueva V; Ojeda J; Rocamora RA; Serrano-Castro PJ; Parra J; Rodríguez-Uranga JJ; Bathal H; Viteri C
    Neurologia (Engl Ed); 2018 Jun; 33(5):290-300. PubMed ID: 27349151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Na
    McKerrall SJ; Sutherlin DP
    Bioorg Med Chem Lett; 2018 Oct; 28(19):3141-3149. PubMed ID: 30139550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voltage gated sodium and calcium channel blockers for the treatment of chronic inflammatory pain.
    Rahman W; Dickenson AH
    Neurosci Lett; 2013 Dec; 557 Pt A():19-26. PubMed ID: 23941888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathic pain: preclinical and early clinical progress with voltage-gated sodium channel blockers.
    Kushnarev M; Pirvulescu IP; Candido KD; Knezevic NN
    Expert Opin Investig Drugs; 2020 Mar; 29(3):259-271. PubMed ID: 32070160
    [No Abstract]   [Full Text] [Related]  

  • 7. Conotoxins That Could Provide Analgesia through Voltage Gated Sodium Channel Inhibition.
    Munasinghe NR; Christie MJ
    Toxins (Basel); 2015 Dec; 7(12):5386-407. PubMed ID: 26690478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spider Knottin Pharmacology at Voltage-Gated Sodium Channels and Their Potential to Modulate Pain Pathways.
    Dongol Y; Cardoso FC; Lewis RJ
    Toxins (Basel); 2019 Oct; 11(11):. PubMed ID: 31671792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical guidance and considerations for transitioning patients from oxcarbazepine or carbamazepine to eslicarbazepine acetate--Expert opinion.
    Peltola J; Holtkamp M; Rocamora R; Ryvlin P; Sieradzan K; Villanueva V
    Epilepsy Behav; 2015 Sep; 50():46-9. PubMed ID: 26114438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study.
    Trinka E; Ben-Menachem E; Kowacs PA; Elger C; Keller B; Löffler K; Rocha JF; Soares-da-Silva P
    Epilepsia; 2018 Feb; 59(2):479-491. PubMed ID: 29369348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with eslicarbazepine acetate as treatment for painful diabetic neuropathy.
    Garcia-Escrivà A; López-Herandez N; Lezcano M; Berenguer L
    Neurologia; 2016; 31(9):639-640. PubMed ID: 25681850
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective Ligands and Drug Discovery Targeting the Voltage-Gated Sodium Channel Nav1.7.
    Payandeh J; Hackos DH
    Handb Exp Pharmacol; 2018; 246():271-306. PubMed ID: 29532179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and activity relationship in the (S)-N-chroman-3-ylcarboxamide series of voltage-gated sodium channel blockers.
    Kers I; Csjernyik G; Macsari I; Nylöf M; Sandberg L; Skogholm K; Bueters T; Eriksson AB; Oerther S; Lund PE; Venyike E; Nyström JE; Besidski Y
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5618-24. PubMed ID: 22832315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eslicarbazepine acetate as a therapeutic option in a patient with carbamazepine-induced rash and HLA-A*31:01.
    Kay L; Willems LM; Zöllner JP; Reif PS; Klein KM; Rosenow F; Strzelczyk A
    Seizure; 2017 Apr; 47():81-82. PubMed ID: 28340402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eslicarbazepine Acetate: A New Improvement on a Classic Drug Family for the Treatment of Partial-Onset Seizures.
    Galiana GL; Gauthier AC; Mattson RH
    Drugs R D; 2017 Sep; 17(3):329-339. PubMed ID: 28741150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoform selective voltage-gated sodium channel modulators and the therapy of pain.
    Jukič M; Kikelj D; Anderluh M
    Curr Med Chem; 2014; 21(2):164-86. PubMed ID: 24059240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aptiom (eslicarbazepine acetate) as a dual inhibitor of β-secretase and voltage-gated sodium channel: advancement in Alzheimer's disease-epilepsy linkage via an enzoinformatics study.
    Shaikh S; Rizvi SM; Hameed N; Biswas D; Khan M; Shakil S; Kamal MA
    CNS Neurol Disord Drug Targets; 2014; 13(7):1258-62. PubMed ID: 25230222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Voltage-Gated Sodium Channels in Pain Signaling.
    Bennett DL; Clark AJ; Huang J; Waxman SG; Dib-Hajj SD
    Physiol Rev; 2019 Apr; 99(2):1079-1151. PubMed ID: 30672368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voltage-gated sodium channel blockers: New perspectives in the treatment of neuropathic pain.
    Alcántara Montero A; Sánchez Carnerero CI
    Neurologia (Engl Ed); 2021 Mar; 36(2):169-171. PubMed ID: 32253051
    [No Abstract]   [Full Text] [Related]  

  • 20. Eslicarbazepine acetate for a patient with highly resistant epicrania fugax.
    Cuadrado ML; Aledo-Serrano Á; Ruiz-Álvarez L
    Pain Pract; 2015 Jan; 15(1):E27. PubMed ID: 25560733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.